03 Follow-up · Pharma
Closing the enquiry follow-up gap for pharma manufacturers
In pharma, buyers are purchase heads at pharma manufacturers. Demand moves with plant audits, tender cycles and new formulations; first contact usually comes through trade directories, referrals and exhibitions. The failure is that technical enquiries are not routed to quality assurance.

Sector context
How Pharma buyers reach this point
Buyers in pharma are usually purchase heads at pharma manufacturers. Demand is created by plant audits, tender cycles and new formulations, and the first filter is GMP, certificate of analysis and audit history. First contact usually comes through trade directories, referrals and exhibitions, which is also where the record often ends. The repeated failure is simple: technical enquiries are not routed to quality assurance.
What this page is
A pattern from the sector and the build that answers it. No figure is published because none has been approved.
01 — Diagnosis
What was going wrong
For a pharma business, the pattern is familiar: plant audits, tender cycles and new formulations brings the enquiry, and technical enquiries are not routed to quality assurance.
- 01
The reply lived in one inbox, so nobody could tell whether an enquiry had been answered at all.
- 02
Plant audits, tender cycles and new formulations filled the pipeline, and technical enquiries are not routed to quality assurance.
- 03
Nothing separated a pharma buyer who was ready from one who was still comparing.
02 — Approach
Our approach
Nothing was added that the team would not use. The work followed the enquiry from trade directories, referrals and exhibitions to a recorded next step.
- 01
One pipeline with an owner, a status and a defined next action for every enquiry.
- 02
Follow-up sequences timed to the pharma buying cycle around plant audits, tender cycles and new formulations.
- 03
A daily view of enquiries with no next action, so nothing goes quiet by accident.
- 04
Handover notes so follow-up survives staff changes and leave.
03 — Publication standard
What this page does not show
- No dates and no figures. Where a performance number would normally sit for follow-up work, this page has none because none has been approved for publication.
- What is checkable: the follow-up problem scoped in section 01 and the build specified below. Both can be walked through on a call.
Cost
What ongoing work costs
Billed monthly. Website development sits outside these plans and is priced per year.
Same sector
More Pharma studies
02 Local visibility
Local search visibility for pharma manufacturers
For pharma manufacturers, the buying trigger is plant audits, tender cycles and new formulations. Enquiries come through trade directories, …
Read the study01 Enquiry system
Qualified enquiry system for pharma manufacturers
For pharma manufacturers, the buying trigger is plant audits, tender cycles and new formulations. Enquiries come through trade directories, …
Read the studyQuestions
Before you ask.
The questions Pharma buyers ask first — answered the way we would answer them on a call.
What does a qualified pharma enquiry look like?
How long does a follow-up build take?
Do you work with our existing CRM?
Get started
Facing something similar?
A short consultation will tell you whether a comparable engagement makes sense for your business — and which part to fix first.
- A written recommendation, not a sales deck
- Scope, sequence and cost before anything starts
- We say no when the work is not worth your money
Request a consultation
Two minutes now saves a discovery call later.